Literature DB >> 11193237

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

P D Delmas1, R Eastell, P Garnero, M J Seibel, J Stepan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11193237     DOI： 10.1007/s001980070002

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  156 in total

1.  Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.

Authors:  C Christiansen; L B Tankó; L Warming; A Moelgaard; S Christgau; P Qvist; M Baumann; L Wieczorek; N Hoyle
Journal:  Osteoporos Int       Date:  2003-06-26       Impact factor: 4.507

Review 2.  Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?

Authors:  J J Stepan
Journal:  J Endocrinol Invest       Date:  2003-05       Impact factor: 4.256

Review 3.  Bone quality: where do we go from here?

Authors:  Mary L Bouxsein
Journal:  Osteoporos Int       Date:  2003-08-29       Impact factor: 4.507

Review 4.  Bone turnover markers: use in osteoporosis.

Authors:  Kim Naylor; Richard Eastell
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

Review 5.  Bone metabolism markers in sports medicine.

Authors:  Giuseppe Banfi; Giovanni Lombardi; Alessandra Colombini; Giuseppe Lippi
Journal:  Sports Med       Date:  2010-08-01       Impact factor: 11.136

Review 6.  Oral contraceptive use and bone.

Authors:  Shuying Wei; Tania Winzenberg; Laura L Laslett; Alison Venn; Graeme Jones
Journal:  Curr Osteoporos Rep       Date:  2011-03       Impact factor: 5.096

7.  Acute effects of plyometric jumping and intermittent running on serum bone markers in young males.

Authors:  Che-Fu Lin; Tsang-hai Huang; Kuo-Cheng Tu; Linda L Lin; Yi-Hsuan Tu; Rong-Sen Yang
Journal:  Eur J Appl Physiol       Date:  2011-08-12       Impact factor: 3.078

8.  Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women.

Authors:  Marlena C Kruger; Yoke Mun Chan; Barbara Kuhn-Sherlock; Lee Ting Lau; ChinChin Lau; Y S Chin; Joanne M Todd; Linda M Schollum
Journal:  Eur J Nutr       Date:  2015-08-12       Impact factor: 5.614

9.  Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy.

Authors:  G Ciana; R Addobbati; G Tamaro; A Leopaldi; M Nevyjel; L Ronfani; L Vidoni; M G Pittis; B Bembi
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

10.  Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.

Authors:  Sherri-Ann M Burnett-Bowie; Kenneth Saag; Anthony Sebba; Anne E de Papp; Erluo Chen; Elizabeth Rosenberg; Susan L Greenspan
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.